Kumar Shivendra, Saha Sunam, Pathak Devender, Singh Talever, Kumar Atul, Singh Kuldeep, Mishra Avinash Kumar, Singh Sakshi, Singh Shubham
Department of Pharmacology, Rajiv Academy for Pharmacy, Mathura, Uttar Pradesh, India.
Department of Pharmacy, United Institute of Technology, Prayagraj, Uttar Pradesh, India.
Recent Adv Food Nutr Agric. 2025;16(1):2-11. doi: 10.2174/012772574X285280240220065812.
Hyperlipidemia, characterized by elevated levels of lipids in the blood, represents a major risk factor for cardiovascular diseases, a leading cause of morbidity and mortality worldwide. Conventional pharmacological interventions have been effective in managing hyperlipidemia, but concerns about side effects and long-term use have prompted interest in alternative approaches, particularly the use of nutraceuticals. This comprehensive review aims to summarize and critically evaluate the current body of knowledge surrounding the role of nutraceuticals in the management of hyperlipidemia. We provide an overview of the different classes of nutraceuticals, including plant sterols, omega-3 fatty acids, soluble fiber, antioxidants, and various herbal extracts, which have been investigated for their lipid-lowering properties. The mechanisms of action of these nutraceuticals are discussed, highlighting their ability to modulate lipid metabolism, reduce oxidative stress, and promote cardiovascular health. Furthermore, we review the results of clinical trials and epidemiological studies that have assessed the efficacy of nutraceutical interventions in lowering cholesterol levels, improving lipid profiles, and reducing the risk of cardiovascular events. In addition to their lipid-lowering effects, we examine the safety profile, dosage recommendations, and potential interactions of nutraceuticals with conventional lipid-lowering medications. We also address the importance of patient adherence to dietary and lifestyle modifications in conjunction with nutraceutical supplementation. While nutraceuticals offer a promising avenue for managing hyperlipidemia, we emphasize the need for further research to establish evidence-based guidelines for their use in clinical practice. Challenges related to standardization, quality control, and regulatory considerations are also discussed. In conclusion, this comprehensive review provides valuable insights into the potential of nutraceuticals as adjunctive or alternative therapies for managing hyperlipidemia. While further research is needed, the accumulating evidence suggests that nutraceuticals can play a valuable role in promoting cardiovascular health and reducing the burden of hyperlipidemia-related diseases.
高脂血症以血液中脂质水平升高为特征,是心血管疾病的主要危险因素,而心血管疾病是全球发病和死亡的主要原因。传统的药物干预在管理高脂血症方面已取得成效,但对副作用和长期使用的担忧促使人们对替代方法产生兴趣,特别是使用营养保健品。这篇全面综述旨在总结和批判性评估目前围绕营养保健品在高脂血症管理中作用的知识体系。我们概述了不同类别的营养保健品,包括植物甾醇、ω-3脂肪酸、可溶性纤维、抗氧化剂以及各种草药提取物,这些都已针对其降脂特性进行了研究。讨论了这些营养保健品的作用机制,强调了它们调节脂质代谢、降低氧化应激以及促进心血管健康的能力。此外,我们回顾了评估营养保健品干预在降低胆固醇水平、改善血脂谱以及降低心血管事件风险方面疗效的临床试验和流行病学研究结果。除了它们的降脂作用外,我们还研究了营养保健品的安全性、剂量建议以及与传统降脂药物的潜在相互作用。我们还强调了患者坚持饮食和生活方式改变并结合营养保健品补充的重要性。虽然营养保健品为管理高脂血症提供了一条有前景的途径,但我们强调需要进一步研究以建立基于证据的临床实践使用指南。还讨论了与标准化、质量控制和监管考虑相关的挑战。总之,这篇全面综述为营养保健品作为管理高脂血症的辅助或替代疗法的潜力提供了有价值的见解。虽然还需要进一步研究,但越来越多的证据表明,营养保健品在促进心血管健康和减轻高脂血症相关疾病负担方面可以发挥重要作用。